Short answer
Cigna (CI) filed its Q3 2025 10-Q quarterly report on Oct 30, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $69.7B (up 9.5% year over year) with net income of $1.9B.
Q3 2025 key financials · XBRL
- Revenue
- $69.7B
- +9.5% YoY · +3.8% QoQ
- Net income
- $1.9B
- +152.8% YoY · +21.9% QoQ
- Operating margin
- 3.7%
- EPS (diluted)
- $6.97
- +166.0% YoY · +22.3% QoQ
Source: XBRL data from the Cigna (CI) Q3 2025 10-Q on SEC EDGAR. USD.
Cigna Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No profitability or margin figures included in provided section
- No segment or product line performance metrics mentioned
- No cash position, operating cash flow, or capital deployment details given
- No management commentary on near-term outlook, guidance, or headwinds available
Risk Factors
- Debt securities portfolio carrying value decreased from $9.4B to $8.4B due to HCSC transaction, unrealized depreciation from rising interest rates
- Commercial mortgage loan portfolio $1.3B with <25% exposure to office properties amid weak sector fundamentals beginning to stabilize
- Other long-term investments $4.9B, diversified with no single partnership >3% and <4% exposure to office real estate, expecting continued valuation volatility
- Unconsolidated subsidiary joint venture in China holds $17.4B investment portfolio, no material unrealized losses as of September 30, 2025
- Market risk exposure to interest rate risk unchanged from 2024 Form 10-K, no material change in risk profile reported
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Cigna quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.